Results 171 to 180 of about 1,405,405 (194)

Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center. [PDF]

open access: yesBiomedicines
Alexeeva EI   +14 more
europepmc   +1 more source

Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. [PDF]

open access: yesPediatr Rheumatol Online J
Correll C   +12 more
europepmc   +1 more source

Systemic-onset juvenile idiopathic arthritis

open access: yesAutoimmunity Reviews, 2016
Systemic-onset juvenile idiopathic arthritis (SoJIA) is a systemic inflammatory disease which has up to now been classified as a category of juvenile idiopathic arthritis.
Rolando Cimaz
exaly   +2 more sources

Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives

Annals of Medicine, 2022
Karen Onel   +2 more
exaly  

Treatment of systemic juvenile idiopathic arthritis

Nature Reviews Rheumatology, 2023
Claas Hinze   +2 more
exaly  

Systemic juvenile idiopathic arthritis

Autoimmunity Reviews, 2012
Alberto MARTINI
exaly  

Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis

Therapeutic Advances in Musculoskeletal Disease, 2012
Tadamitsu Kishimoto
exaly  

Home - About - Disclaimer - Privacy